Stage I and II Low-to-Intermediate-Risk Thyroid Cancer Can Be Treated Without Radioactive Iodine Using Postoperative Non-suppressed Thyroglobulin
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Only registered members have full access to PracticeUpdate content.